Steps against the burden of Parkinson's disease (StepuP): Protocol of a randomized controlled trial elucidating the biomechanical and neurophysiological mechanisms of a speed dependent treadmill training intervention

The "StepuP" randomized controlled trial protocol outlines a study recruiting 126 individuals with Parkinson's disease to investigate the biomechanical and neurophysiological mechanisms—specifically stability-related foot placement and cortical sensorimotor integration—underlying the efficacy of speed-dependent treadmill training, with or without virtual reality and mechanical perturbations, to improve gait and daily mobility.

The Gist

Imagine your brain is the CEO of your body, and your legs are the delivery trucks that need to move you from point A to point B. In Parkinson's disease, the CEO gets a bit "glitchy." It sends confusing signals, making the trucks move too slowly, take tiny steps, and struggle to keep their balance. This makes walking feel like driving a car with a sticky steering wheel on a bumpy road, leading to a high risk of falling.

For a long time, doctors have known that Speed-Dependent Treadmill Training (SDTT) helps. It's like putting those delivery trucks on a conveyor belt that moves at a steady, fast pace. The trucks (legs) get used to the rhythm, and eventually, they walk better even when the belt is gone.

But here's the big mystery: How exactly does this work? Is it just the muscles getting stronger? Or is the "CEO" (the brain) learning a new way to drive? And does training on a treadmill actually help people walk better in their messy, real-world lives (like navigating a crowded grocery store)?

This is where the StepuP study comes in. Think of it as a massive, international "detective squad" trying to solve the case of Parkinson's walking.

The Mission: "StepuP"

The researchers are running a huge experiment across four different countries (Germany, Israel, Australia, and Italy) to figure out the secret sauce behind treadmill training. They want to know:

1. Does it work? (Yes, they expect it to.)
2. Why does it work? (Is it fixing the brain's software or the body's hardware?)
3. Can we make it even better? (By adding "gymnastics" to the treadmill routine.)

The Experiment: The "Gym" vs. The "Obstacle Course"

The study involves 126 people with Parkinson's. They are split into two teams:

• Team A (The Standard Crew): They get the standard treadmill training. The belt moves at a speed that challenges them, but it's a smooth, predictable ride.
• Team B (The Super Crew): They get the same training, but with extra challenges (called "SDTT+").
  • Some have to step over virtual obstacles that pop up on a screen (like a video game).
  • Some have to deal with the treadmill suddenly speeding up or slowing down (like a bus lurching forward).
  • Some get both!

The idea is that just like a pilot trains in a flight simulator with turbulence, adding these "surprises" might teach the brain to be more flexible and reactive, not just rhythmic.

The "Black Box" Recorders

Here is the coolest part. While these people are walking, the researchers aren't just watching them; they are listening to the engine and the GPS.

1. The Brain GPS (EEG): They put a special cap on the participants' heads with 64 sensors. It's like a high-tech microphone listening to the brain's "radio waves." They are specifically looking for a specific frequency (the "beta band") that acts like a "stuck gear" in Parkinson's. They want to see if the training helps the brain shift out of that stuck gear and start driving smoothly again.
2. The Muscle Engine (EMG): They stick small sensors on the leg muscles to see how the "trucks" are firing.
3. The Balance Check: They use cameras to track exactly where the feet land. In Parkinson's, feet often land in the wrong spot, like trying to park a car in a tight space without looking. The study checks if the training helps the feet land perfectly in the right spot to keep balance.

The Real-World Test

After the training, the participants go home. But they don't just go home; they wear a small sensor on their lower back (like a tiny fitness tracker) for a week. This records how they walk in their real life—walking to the kitchen, going to the store, or walking the dog.

This is crucial because sometimes people get better in the lab but forget how to do it in the real world. The researchers want to know: Did the training stick?

The Goal: Personalized Medicine

Right now, treadmill training is a bit of a "one-size-fits-all" approach. Some people get amazing results; others don't change much.

The StepuP study wants to build a user manual for the brain. By combining the brain data, the muscle data, and the real-life walking data, they hope to create a system that can predict:

• "If you have this type of brain signal, you should try the Virtual Reality treadmill."
• "If you have that type of muscle pattern, you should try the Speed-Changing treadmill."

Why This Matters

Imagine if, instead of guessing which medicine or therapy works for a patient, doctors could say, "Based on your brain's 'radio waves' and your walking style, this specific type of treadmill training will fix your balance."

This study is like a massive data-gathering mission to unlock the secrets of how we move. If they succeed, they won't just be teaching people with Parkinson's how to walk faster; they'll be teaching them how to walk with confidence and safety, reducing the fear of falling and helping them stay independent for longer.

In short: They are putting Parkinson's patients on high-tech treadmills with video games and surprise bumps, while listening to their brains and muscles, to figure out exactly how to retrain the brain to walk better in the real world.

Technical Summary

Based on the provided preprint, here is a detailed technical summary of the StepuP (Steps against the burden of Parkinson's disease) protocol.

1. Problem Statement

Parkinson's disease (PD) significantly impairs gait and stability, leading to high fall rates (up to 70% annually) and reduced independence. While Speed-Dependent Treadmill Training (SDTT) is clinically effective at improving gait speed and stride length, the specific biomechanical and neurophysiological mechanisms driving these improvements remain poorly understood. Furthermore, it is unclear whether these laboratory-based improvements translate to daily-life mobility or if adding complex task demands (e.g., virtual reality or perturbations) enhances efficacy. There is also a need to identify why individual responses to training vary so significantly.

2. Methodology

The StepuP study is a multicenter, randomized controlled trial (RCT) involving four clinical sites (Bologna, Kiel, Tel Aviv, Sydney) and a reference site (Amsterdam).

• Participants:

  • 126 individuals with Parkinson's disease (Hoehn & Yahr stages I–III).
  • 21 healthy older adults (Amsterdam) serving as a reference group.
  • Randomization is stratified by site and H&Y stage into two groups:
    • Control Group (SDTT): Standard speed-dependent treadmill training.
    • Intervention Group (SDTT+): SDTT enriched with additional destabilizing or context-enriching components.
      • Bologna/Tel Aviv: Virtual Reality (VR) obstacles (proactive adaptation).
      • Kiel: Mechanical perturbations (accelerations/decelerations) (reactive adaptation).
      • Sydney: Combination of VR and mechanical perturbations.

• Intervention Protocol:

  • Duration: 12 sessions over ~4 weeks (30 mins/session).
  • Progression: Training speed is individually tailored based on the participant's Comfortable Walking Speed (CST), progressing from 80% to 110% of CST.
  • Maintenance: Post-intervention, all participants use a mobile app ("Walking Tall") for home-based speed-dependent walking.

• Assessment Timeline:

  • T0 (Baseline): Clinical, functional, and biomechanical assessments.
  • T1 (Post-Intervention): Immediate follow-up.
  • T2 (12-week Follow-up): Long-term retention assessment.
  • Note: In Sydney, a subset undergoes a second baseline (T-1) to establish measurement reliability.

• Data Collection (Multimodal):

  • Clinical: MDS-UPDRS-III, Mini-BESTest, 20-meter walk test, fear of falling, and quality of life scales.
  • Biomechanics: 3D Motion Capture (Qualisys/Vicon) with a minimal marker set (heel, pelvis, foot) to quantify foot placement control.
  • Neurophysiology:
    • 64-channel EEG: Wireless (Smarting X Pro, g.Nautilus, or TMSi Saga) to measure cortical beta-band (13–30 Hz) activity and corticomuscular coherence.
    • EMG: Surface electrodes on leg muscles (e.g., Rectus Femoris, Tibialis Anterior) to assess muscle activation and sensorimotor integration.
  • Real-World Monitoring: 7-day unsupervised data collection using Inertial Measurement Units (IMUs) on the lower back (and shanks for a subgroup) to track daily gait quantity and quality.
  • Qualitative: Diaries, questionnaires (SUS, PACES), and semi-structured interviews to assess engagement and barriers.

• Statistical Analysis:

  • Primary Endpoint: Change in comfortable overground walking speed (20m walk test).
  • Mechanistic Analysis: Linear mixed-effects models to correlate training effects with changes in foot placement models (step length vs. Center of Mass state), beta power, and corticomuscular coherence.
  • Machine Learning: Exploratory models to identify predictors of "responders" vs. "non-responders" using multimodal data.

3. Key Contributions

• Mechanistic Elucidation: This is one of the first studies to simultaneously capture cortical (EEG), muscular (EMG), and kinematic data during treadmill walking in PD to link gait improvements to stability-related foot placement control and sensorimotor integration.
• SDTT+ Protocols: It systematically compares standard training against enriched protocols (VR and perturbations) to determine if adding reactive/proactive challenges yields superior transfer to daily life.
• Real-World Translation: By combining lab-based mechanistic data with 7-day IMU monitoring, the study directly addresses the "transfer gap" between clinical improvements and daily-life mobility.
• Open Science Framework: The consortium commits to open-access data (OpenNeuro, MJFF), public release of synchronization scripts (LSL), and analysis pipelines to ensure reproducibility.
• Ethical Design: Utilizes a "second baseline" design in some arms rather than a pure no-treatment control group to ensure all participants eventually receive effective therapy, balancing scientific rigor with ethical obligations.

4. Results

• Status: As this is a protocol paper (preprint posted March 2026), no empirical results or outcomes are reported yet.
• Hypotheses: The study hypothesizes that:
  1. SDTT will improve gait speed (H1).
  2. Improvements are mediated by enhanced stability-related foot placement control (H2).
  3. Foot placement improvements correlate with changes in cortical beta activity and corticomuscular coherence (H3).
  4. SDTT+ will show added value over standard SDTT, particularly in transferring to daily life.

5. Significance

• Personalized Rehabilitation: By identifying the specific biomechanical and neural mechanisms that respond to training, the study aims to distinguish "responders" from "non-responders." This could lead to personalized rehabilitation strategies where specific training types (e.g., perturbations vs. VR) are prescribed based on an individual's specific deficits.
• Fall Prevention: Understanding the link between foot placement control, cortical integration, and stability could lead to more effective interventions to reduce the high fall risk in PD.
• Global Applicability: The international consortium (Europe, Asia, Australia) allows for the investigation of cultural and environmental factors on PD gait and training response, potentially revealing disparities in disease presentation and treatment efficacy.
• Scientific Advancement: The use of mobile, wireless EEG during gait in PD provides a novel dataset for understanding the role of the motor cortex in dynamic stability, potentially refining models of PD pathophysiology.